Urru et al. have demonstrated that tumor stage at diagnosis and positive lymph node ratio are relevant predictors of survival and tumor recurrence, with the addition of Ki-67 status for recurrence prediction [12]. The gene discussed is MKI67; the disease is neoplasm.